Clinical significance and gene expression study of human hepatic stellate cells in HBV related-hepatocellular carcinoma
Open Access
- 19 April 2013
- journal article
- research article
- Published by Springer Science and Business Media LLC in Journal of Experimental & Clinical Cancer Research
- Vol. 32 (1), 22-10
- https://doi.org/10.1186/1756-9966-32-22
Abstract
Background Peritumoral activated hepatic stellate cells (HSCs) are versatile myofibroblast-like cells closely related with hepatocellular carcinoma (HCC) progression. So far, comprehensive comparison of gene expression of human HSCs during hepatocarcinogenesis is scanty. Therefore, we identified the phenotypic and genomic characteristics of peritumoral HSCs to explore the valuable information on the prognosis and therapeutic targets of HBV related HCC. Methods A tissue microarray containing 224 HBV related HCC patients was used to evaluate the expression of phenotype markers of HSCs including α-SMA, glial fibrillary acidic protein (GFAP), desmin, vinculin and vimentin. HSCs and cancer associated myofibroblasts (CAMFs) were isolated from normal, peritumoral human livers and cancer tissues, respectively. Flow cytometry and gene microarray analysis were performed to evaluate the phenotypic changes and gene expression in HCC, respectively. Results Peritumoral α-SMA positive HSCs showed the prognostic value in time to recurrence (TTR) and overall survival (OS) of HCC patients, especially in early recurrence and AFP-normal HCC patients. Expression of GFAP positive HSCs cell lines LX-2 was significantly decreased after stimulation with tumor conditioned medium. Compared with quiescent HSCs, peritumoral HSCs and intratumoral CAMFs expressed considerable up- and down-regulated genes associated with biological process, cellular component, molecular function and signaling pathways involved in fibrogenesis, inflammation and progress of cancer. Conclusions Peritumoral activated HSCs displayed prognostic value in HBV related-HCC, and their genomic characteristics could present rational biomarkers for HCC risk and promising therapeutic targets.Keywords
This publication has 34 references indexed in Scilit:
- Hallmarks of Cancer: The Next GenerationCell, 2011
- The Control of the Metabolic Switch in Cancers by Oncogenes and Tumor Suppressor GenesScience, 2010
- Risk of HCC: Genetic heterogeneity and complex geneticsJournal of Hepatology, 2009
- Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instabilityCarcinogenesis: Integrative Cancer Research, 2009
- Gene Expression in Fixed Tissues and Outcome in Hepatocellular CarcinomaThe New England Journal of Medicine, 2008
- High Expression of Macrophage Colony-Stimulating Factor in Peritumoral Liver Tissue Is Associated With Poor Survival After Curative Resection of Hepatocellular CarcinomaJournal of Clinical Oncology, 2008
- Oncogenes and CancerThe New England Journal of Medicine, 2008
- Prediction of venous metastases, recurrence, and prognosis in hepatocellular carcinoma based on a unique immune response signature of the liver microenvironmentCancer Cell, 2006
- A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cellsNature Medicine, 2006
- Genetic heterogeneity of hepatocellular carcinoma.Proceedings of the National Academy of Sciences of the United States of America, 1994